Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/13/2012WO2012119212A1 Imidazolidine and thiazolidine molecules with anti-t. cruzi activity
09/13/2012WO2012095726A8 Pharmaceutical combination containing glucosamine salts and paracetamol for the treatment of osteoarthritis
09/13/2012WO2012093234A3 Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus
09/13/2012WO2012092395A3 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof
09/13/2012WO2012091628A3 Substituted hydrogenated thieno-pyrrolo[3,2-c]pyridine, ligands, a pharmaceutical composition and a method for using the above
09/13/2012WO2012090043A8 Novel solid state forms of azilsartan medoxomil and preparation thereof
09/13/2012WO2012088519A3 Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders
09/13/2012WO2012087182A3 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
09/13/2012WO2012082821A3 Melanoma treatments
09/13/2012WO2012082470A3 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
09/13/2012WO2012079057A3 Use of jasmonate for improving skeletal muscle function
09/13/2012WO2012079032A3 Compositions and methods of treating drug-resistant retroviral infections
09/13/2012WO2012078859A3 Protein kinase d inhibitors
09/13/2012WO2012078633A8 Methods of inhibiting metastasis from cancer
09/13/2012WO2012074437A3 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
09/13/2012WO2012073047A3 Compositions and methods
09/13/2012WO2012072791A3 2-(1-phenyl-4,5,6,7-tetrahydro-1h-indazol-4-yl)ethylamine derivatives useful as sigma receptor inhibitors
09/13/2012WO2012072570A3 Process for the preparation of a ppi-containing pharmaceutical product
09/13/2012WO2012071383A9 Methods and compositions to eliminate chronic lymphocytic leukemia and other hematologic malignant cells in stromal microenvironment for cancer therapy
09/13/2012WO2012063005A3 Pharmaceutical composition and dosage form comprising dronedarone, and preparation method thereof
09/13/2012WO2012053003A8 A novel herbal oil for controlling blood sugar without risk of hypoglycemea
09/13/2012WO2012026907A3 Cefpodoxime proxetil formulations
09/13/2012WO2011146583A3 Nanoparticulate cinacalcet formulations
09/13/2012WO2011131203A3 A solid pharmaceutical composition for neutralizing stomach acid
09/13/2012WO2011103524A8 Cyclic tetrapeptides and therapeutic applications thereof
09/13/2012WO2011103130A8 Aminothiazolones as estrogen related receptor-alpha modulators
09/13/2012WO2011100838A8 Derivatives of 1-phenyl-1,5-dihydro-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication
09/13/2012WO2009137291A8 Spiroazaindoles
09/13/2012US20120232463 De novo synthesis of bacteriochlorins
09/13/2012US20120232284 Polymorph of a Pharmaceutical
09/13/2012US20120232163 Methods of making olive juice extracts containing reduced solids
09/13/2012US20120232162 Use of lutein containing compositions to improve certain aspects of memory
09/13/2012US20120232159 Methods and Compositions for Treating Depression using Cyclobenzaprine
09/13/2012US20120232158 Methods of treating hyperacidic disorders
09/13/2012US20120232157 Methods of using derivatives of (-)-venlafaxine
09/13/2012US20120232156 Controlled release dosage forms
09/13/2012US20120232155 Novel antibacterial hydroxyphenyl compound
09/13/2012US20120232152 Topical ibuprofen formulations
09/13/2012US20120232151 Process for the Preparation of Gadobenate Dimeglumine Complex in a Solid Form
09/13/2012US20120232150 Phthalanilate compounds and methods of use
09/13/2012US20120232149 Solid pharmaceutical compositions containing pregabalin
09/13/2012US20120232148 Systems and Methods for Preventing Cancer and Treating Skin Lesions
09/13/2012US20120232147 Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof
09/13/2012US20120232146 Methods of and Systems for Producing Diesel Blend Stocks
09/13/2012US20120232145 Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy
09/13/2012US20120232144 Methods of and Systems for Producing Diesel Blend Stocks
09/13/2012US20120232143 Lipid derivatives
09/13/2012US20120232142 Novel use of dimethylfumarate
09/13/2012US20120232141 Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
09/13/2012US20120232140 Pharmaceutical combination of prostaglandin compound and nsaid for the treatment of glaucoma and ocular hypertension
09/13/2012US20120232139 Composition for ocular topical administration treatment ocular hypertension and glaucoma
09/13/2012US20120232138 Amidoacetonitrile compounds having pesticidal activity
09/13/2012US20120232137 Use of Bethaneciol for Treatment of Xerostomia
09/13/2012US20120232136 Substance with sedative effect
09/13/2012US20120232135 (-)-Epigallocatechin Gallate Derivatives for Inhibiting Proteasome
09/13/2012US20120232134 Combination cancer therapy with bis(thiohydrazide) amide compounds
09/13/2012US20120232133 Delivery of proteins using adeno-associated virus (aav) vectors
09/13/2012US20120232132 Rna antagonists targeting gli2 for the treatment of leukemia
09/13/2012US20120232131 Gene expression and pain
09/13/2012US20120232129 Multiantivirus compound, composition and method for treatment of virus diseases
09/13/2012US20120232128 Treatment of influenza
09/13/2012US20120232127 Regulation of neurotransmitter release through anion channels
09/13/2012US20120232126 Multi-targets interfering rna molecules and their applications
09/13/2012US20120232125 Modulation of diacylglycerol acyltransferase 1 expression
09/13/2012US20120232124 Compositions and methods for prognosis and treatment of prostate cancer
09/13/2012US20120232123 Liquid pharmaceutical compositions
09/13/2012US20120232122 Tricyclic heterocyclic derivatives
09/13/2012US20120232121 Use of sarcoplasmic ca2+-atpase type 2 protein for diagnosing and treating learning or mental disorders
09/13/2012US20120232120 Amino acid amides of phenoxybutyric acid derivatives
09/13/2012US20120232119 Method for treating a keratoconjunctival disorder
09/13/2012US20120232118 Selective ligands for the dopamine 3 (d3) receptor and methods of using the same
09/13/2012US20120232117 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
09/13/2012US20120232116 Novel fxr (nr1h4) binding and activity modulating compounds
09/13/2012US20120232115 Pharmaceutical, dietary supplement, and food grade salts of anatabine
09/13/2012US20120232114 Compositions containing opioid antagonists
09/13/2012US20120232113 Methods of treating emesis using growth hormone secretagogues
09/13/2012US20120232112 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
09/13/2012US20120232111 Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin
09/13/2012US20120232110 Antimicrobial Compounds
09/13/2012US20120232109 3-substituted sulfonyl piperidine derivative
09/13/2012US20120232108 Gamma secretase modulators
09/13/2012US20120232107 Non-peptide antagonists of gastrin releasing peptide
09/13/2012US20120232106 Treatment for discoid lupus
09/13/2012US20120232105 Pharmaceutical composition for inhibiting osteoclast growth
09/13/2012US20120232104 Novel sulfonamides as l-cpt1 inhibitors
09/13/2012US20120232103 Novel 5-fluorouracil derivative
09/13/2012US20120232102 Methods Of Administration And Treatment
09/13/2012US20120232101 Novel Compounds
09/13/2012US20120232100 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
09/13/2012US20120232099 Compounds for the Treatment of Hepatitis C
09/13/2012US20120232098 Methods of predicting and treating adverse cardiac events
09/13/2012US20120232097 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
09/13/2012US20120232096 Benzofuran derivatives
09/13/2012US20120232095 Benzofuran derivatives
09/13/2012US20120232094 Use of adrenergic n-phenylpiperazine antagonists, pharmaceutical compositions containing them, and methods of preparing them
09/13/2012US20120232093 Pyrazole derivatives as sigma receptor inhibitors
09/13/2012US20120232092 Heterocyclic sulfonamides
09/13/2012US20120232091 Polymorphic Forms of Manidipine
09/13/2012US20120232090 Arylpiperazine-containing purine derivatives and uses thereof
09/13/2012US20120232089 Method of treating an anxiety disorder
1 ... 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 ... 7860